Registro:

Referencias:

• Sirén, A.-L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Ghezzi, P., Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress (2001) Proc. Natl. Acad. Sci. U. S. A., 98, pp. 4044-4049
• Celik, M., Gokmen, N., Erbayraktar, S., Akhisaroglu, M., Konakc, S., Ulukus, C., Genc, S., Brines, M., Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury (2002) Proc. Natl. Acad. Sci. U. S. A., 99, pp. 2258-2263
• Rui, T., Feng, Q., Lei, M., Peng, T., Zhang, J., Xu, M., Abel, E.D., Kvietys, P.R., Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1 (2004) Cardiovasc. Res., 65, pp. 719-727
• Noguchi, C.T., Asavaritikrai, P., Teng, R., Jia, Y., Role of erythropoietin in the brain (2007) Clin. Rev. Oncol. Hematol., 64, pp. 159-171
• Leist, M., Ghezzi, P., Grasso, G., Bianchi, R., Villa, P., Fratelli, M., Savino, C., Brines, M., Derivatives of erythropoietin that are tissue protective but not erythropoietic (2004) Science, 305, pp. 239-242
• Brines, M., Grasso, G., Fiordaliso, F., Sfacteria, A., Ghezzi, P., Fratelli, M., Latini, R., Cerami, A., Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor (2004) Proc. Natl. Acad. Sci. U. S. A., 101, pp. 14907-14912
• Coleman, T., Westenfelder, C., Tögel, F., Yang, Y., Hu, Z., Swenson, L.A., Leuvenink, H.G., Brines, M., Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities (2006) Proc. Natl. Acad. Sci. U. S. A., 103, pp. 5965-5970
• Fantacci, M., Bianciardi, P., Caretti, A., Coleman, T.R., Cerami, A., Brines, M., Samaja, M., Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxia (2006) Proc. Natl. Acad. Sci. U. S. A., 103, pp. 17531-17534
• Brines, M., Cerami, A., Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response (2008) J. Intern. Med., 264, pp. 405-432
• Um, M., Gross, A.W., Lodish, H.F., A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells (2006) Cell. Signal., 19, pp. 634-645
• Habeeb, A.F., Determination of free amino groups in proteins by trinitrobenzenesulfonic acid (1966) Anal. Biochem., 14, pp. 328-336
• Garbossa, G., Gutnisky, A., Nesse, A., The inhibitory action of aluminum on mouse bone marrow cell growth: evidence for an erythropoietin- and transferrin-mediated mechanism (1994) Miner. Electrolyte Metab., 20, pp. 141-146
• Vittori, D., Nesse, A., Pérez, G., Garbossa, G., Morphologic and functional alterations of morphologic and functional alterations of erythroid cells induced by long-term ingestion of aluminium (1999) J. Inorg. Biochem., 76, pp. 113-120
• Vittori, D., Pregi, N., Pérez, G., Garbossa, G., Nesse, A., The distinct erythropoietin functions that promote cell survival and proliferation are affected by aluminum exposure through mechanisms involving erythropoietin receptor (2005) Biochim. Biophys. Acta, 1743, pp. 29-36
• Callero, M., Vota, D.M., Chamorro, M.E., Wenker, S.D., Vittori, D.C., Nesse, A.B., Calcium as a mediator between erythropoietin and protein tyrosine phosphatase 1B (2010) Arch. Biochem. Biophys., 505, pp. 242-249
• Wenker, S.D., Chamorro, M.E., Vota, D.M., Callero, M.A., Vittori, D.C., Nesse, A.B., Differential antiapoptotic effect of erythropoietin on undifferentiated and retinoic acid-differentiated SH-SY5Y cells (2010) J. Cell. Biochem., 110, pp. 151-161
• Pregi, N., Vittori, D., Pérez, G., Pérez Leirós, C., Nesse, A., Effect of erythropoietin on staurosporine-induced apoptosis and differentiation of SH-SY5Y neuroblastoma cells (2006) Biochim. Biophys. Acta, 1763, pp. 238-246
• Laemmli, U.K., Cleavage of structural protein during the assembly for the head of bacteriphage T4 (1970) Nature, 227, pp. 680-685
• Nakao, T., Geddis, A., Fox, N., Kaushansky, K., PI3K/Akt/FOXO3a pathway contributes to thrombopoietin-induced proliferation of primary megakaryocytes in vitro and in vivo via modulation of p27kip1 (2008) Cell Cycle, 7, pp. 257-266
• Koury, M.J., Sawyer, S.T., Brandt, S.J., New insights into erythropoiesis (2002) Curr. Opin. Hematol., 9, pp. 93-100
• Sautina, L., Sautin, Y., Beem, E., Zhou, Z., Schuler, A., Brennan, J., Zharikov, S.I., Segal, M.S., Induction of nitric oxide by erythropoietin is mediated by the β common receptor and requires interaction with VEGF receptor 2 (2010) Blood, 115, pp. 896-905
• Su, K.H., Shyue, S.K., Kou, Y.R., Ching, L.C., Chiang, A.N., Yu, Y.B., Chen, C.Y., Lee, T.S., β common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase (2011) J. Cell. Physiol., 226, pp. 3330-3339
• Masuda, S., Nagao, M., Takahata, K., Konishi, Y., Gallyas, F., Tabira, T., Sasaki, R., Functionally erythropoietin receptor of the cells with neural characteristics: comparison with receptor properties of erythroid cells (1993) J. Biol. Chem., 268, pp. 11208-11216
• Hanazono, Y., Sasaki, K., Nitta, H., Yazaki, Y., Hirai, H., Erythropoietin induces tyrosine phosphorylation of the beta chain of the GM-CSF receptor (1995) Biochem. Biophys. Res. Commun., 208, pp. 1060-1066
• Jubinsky, P.T., Krijanovski, O.I., Nathan, D.G., Tavernier, J., Sieff, C.A., The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor (1997) Blood, 90, pp. 1867-1873
• Sánchez, P., Navarro, F., Fares, R., Nadam, J., Georges, B., Moulin, C., Cavorsin, M., Bezin, L., Erythropoietin receptor expression is concordant with erythropoietin but not with common β chain expression in the rat brain throughout the life span (2009) J. Comp. Neurol., 514, pp. 403-414
• Walrafen, P., Verdier, F., Kadri, Z., Chrètien, S., Lacombe, C., Mayeux, P., Both proteasomes and lysosomes degrade the activated erythropoietin receptor (2005) Blood, 105, pp. 600-608
• Murphy, J.M., Young, I.G., IL-3, IL-5, and GM-CSF signaling: crystal structure of the human beta-common receptor (2006) Vitam. Horm., 74, pp. 1-30
• Chrétien, S., Varlet, P., Verdier, F., Gobert, S., Cartron, J.-P., Gisselbrecht, S., Mayeux, P., Lacombe, C., Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation (1996) EMBO J., 15, pp. 4174-4181
• Nakamura, Y., Komatsu, N., Nakauchi, H., A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells (1992) Science, 257, pp. 1138-1141
• Arcasoy, M.O., Jiang, X., Haroon, Z.A., Expression of erythropoietin receptor splice variants in human cancer (2003) Biochem. Biophys. Res. Commun., 307, pp. 999-1007
• Maiese, K., Chong, Z., Shang, Y., Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies (2008) Progr. Neurobiol., 85, pp. 194-213
• Chong, Z.Z., Maiese, K., Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein, and FOXO3a nuclear trafficking to preserve endothelial cell integrity (2007) Br. J. Pharmacol., 150, pp. 839-850
• Ramirez, R., Carracedo, J., Nogueras, S., Buendia, P., Merino, A., Cañadillas, S., Rodríguez, M., Aljama, P., Carbamylated darbepoetin derivative prevents endothelial progenitor cell damage with no effect on angiogenesis (2009) J. Mol. Cell. Cardiol., 47, pp. 781-788
• Xu, X., Cao, Z., Cao, B., Li, J., Guo, L., Que, L., Ha, L., Li, Y., Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism (2009) Surgery, 146, pp. 506-514

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------